SCROLL NEWS / DISCOVERY
Search headlines
Find the stories shaping the conversation.
Results for " bad " 3,427 found 🔀 AI-powered Shuffle
Government overreach won’t fix youth gender medicine
The real cure for bad science is better clinical trials, not lawsuits.
Anaheim Ducks help Wisconsin Badgers extend major NHL draft milestone
This weekend's NHL Draft marks 29 straight where the Wisconsin Badgers have had a player selected.
Carman: Tuesday’s election is more than just a primary. It’s a colossal opportunity to change history.
The template for tyrants goes back at least to Ancient Rome and, as Nero discovered, generally ends badly.
Scratching that bug bite might feel good at first but science explains why it's a bad idea
You've likely heard it since childhood: Don't scratch that bug bite or rash, you'll make it worse. But why would something that feels so good be bad?
Bad news: Netflix now wants every single profile in your house to have its own email login
Netflix quietly updates how shared accounts work
Scratching that bug bite might feel good at first but science explains why it's a bad idea
Now researchers better understand why even a mildly annoying itch could put you on an itch-and-scratch cycle if you give in.
Scratching that bug bite might feel good at first but science explains why it's a bad idea
For the summer itchiness of bug bites and poison ivy, dermatologists recommend hydrocortisone cream, calamine lotion or oatmeal baths.
Dear Abby | Mom's rekindling with abusive father feels like a betrayal
Dear Abby: I am estranged from my father and have been since I was 12. (I'm currently 26.) He was emotionally, psychologically and physically abusive to me, and cutting ties
Scratching a bug bite feels good but science says it’s a bad idea
Researchers have gained a better understanding of why we have an itch to scratch.
3 ways you’re working wrong, according to scientists
Stop multitasking.
Scratching that bug bite might feel good at first but science explains why it's a bad idea
You scratched that bug bite and now it's a big itchier bump. Some science explains why scratching really can make things worse, even if you don't break the skin. University of Pittsburgh researchers put tiny “cones of shame” onto mice to help unravel what happens on a cellular level when an itch ...
Scratching that bug bite might feel good at first but science explains why it’s a bad idea
You scratched that bug bite and now it's a big itchier bump.
Scratching that bug bite might feel good at first but science explains why it’s a bad idea
WASHINGTON (AP) — You’ve likely heard it since childhood: Don’t scratch that bug bite or rash, you’ll make it worse. But why would something that feels so good be bad? A lot of things can cause itc…
Scratching that bug bite might feel good at first but science explains why it's a bad idea
You scratched that bug bite and now it's a big itchier bump. Some science explains why scratching really can make things worse, even if you don't break the skin. University
Scratching that bug bite might feel good at first but science explains why it's a bad idea
You’ve likely heard it since childhood: Don’t scratch that bug bite or rash, you’ll make it worse. A lot of things can cause itchiness, sometimes serious diseases. Whatever the cause, doctors have l...
3 foods that seem healthy but may be bad for your heart: cardiologist
A cardiologist said popular "healthy" foods can actually be bad for your heart, since they're highly processed and full of additives like sugar and fat.
Gen Z traders launched a trading platform to fight bad 'finfluencer' advice
Ivan Patriki and Carson Hein founded QuantMap to counter the bad info they say is all over social media and to give traders better tools to succeed.
Days Ahead to Show If Burnham Plays Politics Better Than Starmer
Standing across from Keir Starmer in the Commons chamber this week, opposition leader Kemi Badenoch drew on a particularly violent metaphor for how the Labour Party had ditched him when she conjured up an image of “400 knives stuck in the prime minister’s back.”
From Supergirl to Muse: your complete entertainment guide to the week ahead
Milly Alcock’s Kryptonian hero bops baddies with a superdog in tow, while the Devon band return with another collection of all-caps rock
A Game Of Inches: 4 Takeaways From A Dizzying Iran-Egypt Draw
This was a pulsating game that came down to one call that flipped the knockout round fates of three teams.
Rangers Land 37-Goal Star In Blockbuster Trade With Vegas
The New York Rangers have added a new star forward to their roster.According to TSN’s Darren Dreger, the Rangers have acquired forward Pavel Dorofeyev from the Vegas Golden Knights.Sportnet’s Elliotte Friedman later added that the Rangers are sending the 26th pick of the 2026 Entry Draft, the 92nd pick of this year’s draft, and their […] The post Rangers Land 37-Goal Star In Blockbuster Trade With Vegas appeared first on HEAVY.
‘It’s a bad time to be a normal’: House Republican on current political environment
Rep. Dusty Johnson (R-S.D.) reacts to President Trump's decision to cancel the signing of the bipartisan housing affordability bill. Rep. Johnson also discusses the president’s Iran strategy and the current political environment.
UC San Diego hosts free Comic-Con events, intersecting health and science through fiction
UC San Diego is holding a badge-free series of comic and science-inspired events in tandem through The Science of Story, from July 21-26.
The Year 536 AD Was So Bad It May Have Been the Worst Time in Human History to Be Alive
Volcanoes, famine and plague made 536 a leading candidate for history’s worst year.
Four bad habits tournament golf exposed within my game
What one writer learned from his second tournament round of the year.
Sugar is not uniquely bad for you. But it’s undermining good habits.
Is sugar more harmful than other carbohydrates? The evidence is far from compelling.
Parasite Affecting 1 in 3 People Is a Serious Risk to Human Health, Scientists Warn
More needs to be done.
Kawhi Leonard Seeks Extension – But Not With Current Team
Kawhi Leonard has one year left on his current contract with the Los Angeles Clippers. He’s eligible to sign an extension this summer, and sounds like he’s willing to do get that done. The one caveat: The Clippers aren’t necessarily the team he wants to sign with. Leonard, who turns 35 on June 29, ...
Making Our Own Luck
We are cross-posting a piece that former NIH official Kris Willis wrote for Macroscience. Kris is now the President and Founder of the Woodley Park Institute, for which I’m a board member. Picking winners or hedging bets? Federal science agencies have long wrestled with the question of how to ensure their billions of dollars of grants and contracts result in maximum benefits for Americans. On the surface, it might seem that a goal-oriented, interventionist style of management would be the best policy: prioritize our most pressing problems and distribute funding accordingly.This top-down strategy creates a unique hazard, though: bad choices can send resources in the wrong direction, resulting in slow progress that impedes the delivery of tangible benefits to citizens. Moreover, if decision makers pursue an applied advance when the underlying scientific principles remain poorly understood, they risk costly failures and a loss of support for the research enterprise at large. Examples include Nixon’s 1971 War on Cancer, undertaken on the premise that a cure could be achieved in less than a decade, the drive to build an operational commercial fusion plant by the mid-1990s, and the National Plan to Address Alzheimer’s Disease, which failed to produce the effective treatments and prevention strategies promised by 2025. The contrasting laissez-faire approach is to hedge your bets. If the path to an advance is impossible to predict, then the wisest choice might be to distribute funding to as widely as possible. The main risk of this strategy is that spreading funding thinly may limit the resources available to the most promising research, resulting in the same negative outcomes as the interventionist approach: limited support for the most promising topics, slow progress, and delayed returns. In reality, at science agencies like the National Science Foundation and National Institutes of Health, program managers navigate between these two extremes, setting some funds aside to target high-priority areas and using the rest to cover the widest possible range of meritorious proposals. This middle path seems like the most rational way to proceed, but it still requires making choices. How much should be set aside for high priority topics? What should those topics be? How should we define merit? Expert opinion can provide a helpful guide, but leading experts can have remarkably different opinions about what matters and what should be prioritized. Moreover, experts and administrators alike can be risk averse, giving an edge to high-profile, well-established concepts. What’s really needed is a data-driven framework to help guide decision-making, one that doesn’t simply repackage prestige or incumbency. Recognizing breakthroughs years in advance Many breakthroughs fail to attract funding or recognition at the earliest stages of development. Katalin Karikó, for example, spent years struggling to win grants for work on mRNA that would eventually win her and Drew Weissman a Nobel Prize. Similar stories can be told about Jim Allison’s groundbreaking studies leading to the development of cancer immunotherapy, Stan Pruisner’s demonstration that prions can self-replicate without DNA, or Robin Warren and Barry Marshall’s proof that Helicobacter pylori, not stress, causes ulcers. Yet at some point, the scientific community recognizes and responds to transformative breakthroughs like these. How does that change happen? And what if science funders could identify the areas that are on the cusp of a breakthrough? Those questions led my collaborators and me to study how scientists responded to past breakthroughs. Based on patterns in that data, we developed a means of predicting future breakthroughs, using biomedicine as a proof of concept. It’s worth taking a moment to describe how our approach works. Briefly, our prediction process begins by grouping the 18 million or so peer-reviewed papers in PubMed, the authoritative database of biomedical research, into roughly 50,000 unique topics. A small subset of these topics are so widely acclaimed as breakthroughs that they have been recognized with a major prize like a Nobel or a Lasker Award. We theorized that studying the development of these outliers over time, especially before they gained acclaim, was the key to identifying future instances of them. After defining topics, we chose 21 representative breakthroughs and asked what they looked like before they won prestigious prizes. To answer that question, we re-ran our topic-mapping algorithm repeatedly, winding back the clock one year each time, stringing together the years to follow the progress of each field as it grew and advanced. We found that in each case, the years leading up to a discovery followed a pattern: a burst of papers on a new, rapidly evolving topic, many of which quickly became influential. These characteristics—the percent of papers that are new, the percentage of papers that are brought in from other topics, and the influence of each individual paper—can all be measured separately for any given topic. Together, they act as a predictive signal that is detectable an average of five years before a transformative discovery is made, and up to thirty years before the discovery receives a major prize. Scanning the current research landscape for topics that display this signal allows us to predict what work will likely produce a future breakthrough. Each year we analyzed includes four or five signals, a number that appears to have remained constant across a twenty year time frame. In their classic work on the sociology of science, Bruno Latour and Steve Woolgar established that the desire to participate in a major discovery is an important motivator for scientists as they consider whether they should take up (or abandon) a research problem. Although further work is needed, the simplest explanation for our results is that this behavior is widespread enough to detect at scale. A foundational advance, or something like it, draws the attention of scientists and causes them to change the direction of their research. They vote with their feet, staking their own reputation and careers by publishing on and citing the new idea. That upswell of interest is the foundation of our breakthrough signal. What kind of research does our model identify as a breakthrough? After building a model based on the patterns in our 21 preselected breakthroughs, we tested it by identifying all early signals of discovery from 1994 through 1997. Of the 18 signals we found in that time period, 17 can be traced forward in time to a breakthrough. Examples include super-resolution fluorescence microscopy (see the image above), the directed evolution of proteins and enzymes (Chemistry Nobel, 2018), and sequencing the human genome (National Medal of Science, 2008). The discovery of the role of leptin signaling in obesity is a particularly interesting case study. Around 1950, scientists noticed the existence of a type of lab mouse that suffered from a unique inherited form of obesity. When given the freedom to choose their own diet, these mice ate more than normal and preferred food that was high in fat. Researchers had few clues as to why the animals overate; early experiments pointed to the existence of a soluble ob factor found circulating in the bloodstream that regulated appetite, but its identity was unknown. In 1994, Jeffrey Friedman and colleagues identified and sequenced the ob gene, noting that the protein it encoded appeared to fit the profile of a circulating factor. A year later, a trio of high-profile publications demonstrated that ob was a hormone that regulated body weight and fat deposition by regulating appetite. One of these was co-authored by Friedman, who christened it leptin from the ancient Greek word for thin. Using our model, the data from 1996 make it clear this advance would become a breakthrough. Scientists had flocked to study the biology of the new hormone, generating the flurry of new papers and citations required to produce a signal. One of these demonstrated that serum leptin concentrations reflected the amount of adipose tissue in the human body, providing clinical validation of the earlier mouse studies. Before the identification of leptin, scientists were unable to point to a specific molecule that controlled appetite and adiposity, so that it was impossible to rule out non-physiological causes of obesity; its characterization fundamentally changed our concept of weight gain. In 2010, Friedman and fellow pioneer Douglas Coleman were awarded a Lasker for the discovery. Our work also identifies breakthroughs in clinical practice and behavioral and social sciences, even though these areas are less likely to draw the attention of major prize committees. One example that falls into this category is the introduction of endovascular aneurysm repair, a minimally invasive surgical procedure for the treatment of abdominal aortic aneurysm, a leading cause of death among Americans over the age of 65. Relative to the previous standard of care, it reduces in-hospital mortality by almost four-fold. In 2017, Timothy Chuter received the American College of Surgeons’ prestigious Jacobsen Innovation award for his multiple refinements to the technique. Another under-recognized breakthrough identified by our model is the development of standardized survey instruments to assess the quality of life for HIV+ patients. The antiretroviral cocktails introduced in the mid-1990s reduced AIDS mortality, but treatment came with serious side effects. The new evaluations showed that patients whose disease progressed had worse physical functioning than Americans with other chronic diseases, while those who were asymptomatic maintained a health-related quality of life on par with the overall US population. This evidence made it possible for patients and activists to argue that even in the absence of a total cure, and in spite of the side effects, alleviation of symptoms was a worthwhile priority for clinicians. My colleagues and I have failed to identify any significant recognition for the physicians and health policy experts who pioneered this advance, although in 2016, researchers called for the World Health Organization to set targets for good health-related quality of life as part of its framework to end the AIDS pandemic. From forecasting to funding How should science funders use our predictions? Any serious discussion of what we should do with this new capability needs to begin with an understanding of its limitations. We can’t (and shouldn’t) invest all of our resources in the small number of topics predicted to produce breakthroughs. Innovative new fields are born from existing ones; they rarely arise de novo. If funders don’t maintain a diverse portfolio, the breakthroughs of tomorrow will have no antecedents. Think of this as eating the seed corn, or killing the goose that lays the golden egg. There are also multiple goals of funding beyond basic scientific discovery, including translating discoveries into clinical practice, developing new technologies, supporting economic development, and training new scientists. The investments needed to accomplish these goals are likely different from those required to support emerging breakthroughs. Finally, we must be aware that we may not capture every instance of a breakthrough. The concept is fuzzy, and not every significant discovery is recognized with a major award. Further, breakthroughs are rare, meaning that our dataset is, by necessity, small. This makes formal estimates of accuracy challenging. Although our overall success rate appears to be high, any one signal may turn out to be a false positive. We found one apparent example: the development of the third generation COX-2 inhibitors, Vioxx and Celebrex, which were much celebrated in the early 2000s as effective but non-addictive pain relievers, meets all the algorithmic criteria of a breakthrough. Five years after it received FDA approval, researchers demonstrated that Vioxx was associated with serious cardiovascular complications, and the manufacturer voluntarily pulled the drug from the market. Celebrex remains available, although like other NSAIDs, it carries an FDA warning for increased cardiovascular risk. Decision makers who were overly focused on the breakthrough potential of this research might have wasted substantial resources nurturing an area that ultimately proved to be a failure—but so would those who relied on expert opinion at the time. That said, the potential benefits of funding the next mRNA vaccine or cancer immunotherapy years earlier than we might have are large. When we can’t assume the outcome of an action, it’s worth conducting an experiment. Can targeted support for areas that are poised to produce a breakthrough increase the return on scientific investment without cannibalizing future advances? With the necessary administrative infrastructure in place, conducting this experiment would be straightforward. First, identify all the breakthrough signals between 2018 and 2023, select half at random, and commit to a decade of investment. For biomedicine, a six year window should yield about 30 topics with the potential to produce a breakthrough. Providing strong support to half of these might be accomplished for $300 million a year. That’s roughly half of the recent annual budget of the NIH Common Fund or around 20% of the fiscal year 2025 budget for ARPA-H. After five years, then again at ten, compare to see which group — the one that was actively managed, or the control — produced more breakthroughs, and on what timescale. Although we used biomedicine as an example, the same experiment could just as well be run for physics, materials science, or any other discipline. Any attempt to undertake such an experiment should keep three points top of mind. First, we can predict the topic of future breakthroughs, but the people and vision for how to move the work forward are still important. In practice, this means success requires active program managers with the expertise to develop the science and the authority to do so, including by recruiting investigators. Second, we would be wise to learn from the failures of past attempts to fund transformative research. High among these are funding modestly repackaged work, confusing the genuinely novel with the merely unfamiliar, and relying too much on incumbent investigators. All of these risks can be mitigated by thoroughly and intelligently integrating high quality data into portfolio management. Finally, we need to have patience. Even with strong funding support, producing a breakthrough takes time. If supporting breakthroughs is the best way to nurture the birth of new fields, we also need to accurately describe and properly manage the other two stages, so that we invest wisely throughout the productive lifetime of ideas and divest once they reach the point of diminishing returns. We would benefit from more study of all of these phases, especially the transition from one to another. More research could answer questions like: When does a breakthrough become an established field? How do the availability of funding, the size and characteristics of the available workforce, and the accumulation of evidence that disagrees with prevailing models affect a field’s decline? Exactly how do old ideas give birth to new ones, and can we speed up the process? The more we understand about the dynamics of scientific progress, the better we can maximize the odds that our curiosity leads to results. I’d call that finding a way to make our own luck.
Why cannabis businesses need to apply for DEA registration now – and why states must help
Cannabis businesses should apply for DEA registration by a Friday, June 26 deadline. And states should be helping them.
What to know about early warnings for earthquakes
Many countries have systems to alert people seconds before shaking begins in an earthquake. Experts say even a slight warning provides critical time for protection.
State health officials investigate Novi death, illnesses after dialysis
Police say no evidence of foul play in death, sicknesses following dialysis at DaVita.
Bungie hit with ‘significant’ layoffs after ending Destiny 2
More bad news for the Marathon studio.
Scientists Analyzed the Bones of ‘Skeleton Lake.’ What They Found Made No Sense.
Roopkund Lake sits in a frozen pocket of the Himalayas where hundreds of people died across a millennium. So why did researchers find bones from the island of Crete there?
Lionel Richie cuts concert short over health issue after sitting down mid-performance
"What I have learned about my years of being in the business. When you are feeling dizzy, sit your ass down," Richie told the crowd.
KUSTOM ENTERTAINMENT, INC. ANNOUNCES BINDING AGREEMENT FOR THE DIVESTITURE OF ITS VIDEO SOLUTIONS SEGMENT TO FULLY COMPLETE LIVE ENTERTAINMENT PIVOT
Transaction Structured to Provide Up to $5.5 Million plus 2,000,000 Warrants to acquire shares of common stock of Cycurion, Inc.; Follows Previously Announced Major Live Music Expansion Partnership with Gilley’s Park City OVERLAND PARK, KS, June 25, 2026 (GLOBE NEWSWIRE) -- Kustom Entertainment, Inc. (Nasdaq: KUST) (the “Company”), a live entertainment and music festival company, today announced it has entered into a binding agreement for the divestiture of its legacy video solutions division to
Country singer Bailey Zimmerman apologizes for canceled concert, charges dropped
Charges against Bailey Zimmerman have been dropped after prosecutors initially accused the country music star of causing $16,000 worth of damage to a New Mexico hotel room and canceling a
Trump’s stunt on the housing bill seems like a very bad idea
President Donald Trump is a familiar legislative arsonist. He’ll often throw curveballs at the last minute that give congressional leaders fits – especially in his own party.
What does CBS Sports think is the best case scenario for the Vikings?
The Vikings season could go one of two ways, what does CBS Sports think is the good way?
Former Disney CEO Bob Iger defends ABC pulling Jimmy Kimmel over Charlie Kirk remark
Bob Iger, who presided over ABC's parent company when Jimmy Kimmel was pulled from the air in 2025, denies that the decision was politically motivated, arguing that Kimmel's comments about Charlie Kirk's murder were 'in bad taste.'
Braves blow another one in 7-6 loss to Padres
A wild night at Petco Park was capped off by a walk-off single by way of Manny Machado as the Braves fell to the Padres, 7-6, in 10 innings. This is a bad baseball team at the moment. The second inning was a doozy for both sides. The Braves loaded the bases and cashed in […]
World Cup business is not booming for some near MetLife Stadium. Here's why.
The owner of a New Jersey diner says World Cup matches at MetLife Stadium have been bad for business.
Gambo: Suns interested in Joshua Jefferson, Baba Miller and others
The Phoenix Suns have targeted a group of six players they would select in the second round of the 2026 NBA Draft, according to John Gambadoro.
South Portland dog park/bar closes after 4 months of business
A Maine restaurant and bar that included an indoor dog park has closed less than five months after it opened for business.
We moved from the US to Barbados. Our 8 kids are more independent now.
Lisa Desai and her husband decided to move to Barbados from Florida because they craved freedom and adventure for their eight kids.
'House of the Dragon' Season 3, episode 1: Aegon originally knelt. Tom Glynn-Carney changed it.
Inside Larys and Aegon's terrible, horrible, no good, very bad road trip.
Warhammer Studio goes super-heavy for an Age of Darkness tank war
Fellblade, Glaive, or Falchion – which is your favourite Warhammer: The Horus Heresy super-heavy tank?
Is watching England play bad for your health?
Watching football is an emotional rollercoaster - but is it good or bad for your health?
Traditional toys benefit children more than virtual entertainment
Click here to view this video from WFXG.com.
Best Buy launches massive anti-Prime Day sale — see 25+ Android deals that might make Amazon look bad
Best Buy is carving up to 50% off smartphones, laptops, and more.
Business Elite Awards Honors Berkeley College Leader Among ‘40 Under 40’ Visionaries
Business Elite Awards, an international organization dedicated to recognizing outstanding leadership and professional excellence, recently honored
How menopause radically changes the brain
The brain undergoes a full renovation during menopause. Although these changes are profound, we’re learning that the long-term impact needn’t be all bad
Resident Evil Creator Says Only Bad Games Can Be Spoiled By Streaming
According to Japanese comedian Hidetaka Kano, Dragon Quest creator Yuji Horii said 'exactly the same thing' as Mikami
Wisconsin’s Medicaid work requirements: Here’s what to know
An estimated 63,000 Wisconsinites could lose BadgerCare Plus as the state prepares to implement new federal Medicaid expansion work requirements next year.
Why shadows on a tennis court cause headaches for players and fans
Every year at some tournaments, stadium design and the sun combine to dazzling effect — in a bad way.
Why the Vikings should pursue Brendan Sorsby in supplemental draft
Here's the case for the Minnesota Vikings taking Brendan Sorsby in the supplemental draft.
'Don't count on me to say bad words' - Live Updates
France's sports minister on Kylian Mbappé's political views, what scares her about snow and why she's not apologizing for PSG.
What are the smoke and health risks from the Boyle Heights fire?
More bad air is expected around the Boyle Heights warehouses that has been burning since Wednesday.
How much preventive health screening should I be getting?
Screenings can find treatable conditions before they’ve caused too much damage – but ‘overscreening’ can cause harm
Opinion: Trump's 'Drill, baby, drill' serves himself, oil companies
“Drill, Baby Drill” domestic oil production was supposed to protect us from international price fixing, bad behavior in the Middle East. It hasn't.
Mississippi Arts and Entertainment Experience unveils new exhibit with panel from author
Daily recording of WTOK's Newscenter 11 at 10
Don’t wear these items to Barry Manilow’s Las Vegas show
An impressionist tried to wear a Barry Manilow wig and jacket to meet Barry Manilow. Bad idea.
Joe Tirio: The most dishonest thing in American politics isn’t a candidate. It’s a map.
"The argument that 'the other side does it too' is the weakest possible defense of a bad practice," McHenry County Clerk Joe Tirio writes of gerrymandering in a guest opinion.
How Michael Landon's “Little House on the Prairie” philosophy influenced “Malcolm in the Middle”
"Malcolm" creator Linwood Boomer cites Landon's approach to working with child actors as an inspiration for how he ran the sitcom.
Success via SNF mental health assistants: How one provider slashed antipsychotics use, bad behavior and hospitalizations
One of the nation’s largest nursing homes is expanding its behavioral health initiatives, offering important insights for caregiving as providers nationwide admit more patients than ever with serious mental illness or other complex diagnoses.
Dear Abby | Keystones of a happy marriage have slowly crumbled
Dear Abby: I'm a gay man who has been married to a wonderful man for seven years (together for 12). Throughout our relationship, my husband has struggled with religious trauma
2026 World Cup: USA Win Over AUS 'Good For America' But 'Bad For Books'
One of the most-bet soccer games in American history resulted in some pain for sportsbooks. Patrick Everson breaks it down.
World Cup fever boosts business in Portland
Portland businesses, from bars to soccer shops, saw a surge in customers and sales as World Cup fans gathered locally to watch the U.S. match despite Seattle hosting the game.
Robert Lewandowski chooses his next club after leaving Barcelona
After four successful seasons in Catalonia, Polish veteran striker Robert Lewandowski said goodbye to Barcelona at the end of the 2025/26 season upon the expiry of his contract.The 37-year-old striker...
New movies to watch this weekend: See 'Toy Story 5' in theaters, rent 'Pressure,' stream 'Project Hail Mary' on MGM+
The "Toy Story" franchise still holds up, but Brendan Fraser's World War II weather drama is ho-hum.
Turkish competition board approves Uber acquisition of Getir delivery business
The Turkish Competition Board said on Friday it had approved Uber Technologies Inc.'s acquisition of the delivery arm of Turkey's Getir from Emirati controlling shareholder Mubadala.
On KC’s Southwest Blvd., no World Cup crowds, business bad: ‘Where is everybody?’
“The streets are quiet, restaurants are empty, and foot traffic is far below expectations,” wrote Caitlin Benedict, owner of Bisou cafe.
High 5 Entertainment’s hiring fair set for early 2027 jobs
High 5 entertainment venue in Estero is progressing with vertical building. Amenities include a pickleball club, bowling alley, bars, golf courses, and a full-service kitchen with memberships and public access.
How New York’s ‘Essential Plan’ insurance coverage cuts are forcing impossible choices
Actor Olivia Killingsworth has a life-threatening genetic condition. She’s one of thousands of New Yorkers facing tough decisions as ‘Essential Plan’ health coverage plan comes to an end.
Young men in UK are not more rightwing than older groups, study says
Analysis shows men aged 18 to 25 are less progressive than women their age, but less likely to vote for rightwing parties than other age groups of men
Sennheiser Joins the Open Wireless Earbud Craze
If you're reading this in the United States, though, we have some bad news.
World Cup panic meter: Brazil, Spain and Portugal all dropped points. Who should be most concerned?
Poll: Only about half of Americans say they can afford quality healthcare
New data from the West Health-Gallup Affordability Index shows that only about half of U.S. adults could afford their healthcare and had access to quality care last year.
High school boys get taste of policy and politics at UW-Eau Claire
Badger Boys State puts incoming high school seniors in the shoes of the government, from the state to the local level.
Former Raiders' RB holds workout with the Dallas Cowboys
White spent the first four years of his career in the Raiders' backfield while struggling to see the field in 2025.
San Pedro Fish Market celebrating 70 years in business | Next Weather in Your Neighborhood
Former Sony Boss Says Xbox Is 'Misunderstanding' The Industry
'The last couple weeks have been a real roller coaster. Feel bad for the dev teams'
Health department orders Wintzell’s Montgomery location to close
A popular seafood restaurant in downtown Montgomery has been ordered to close by the Montgomery County Health Department.
How good (or bad) can it get? The best- and worst-case scenarios for every NFL team in 2026
Can the Cowboys finally break through? Will Patrick Mahomes regain his MVP form? Here are the dream and nightmare outcomes for your favorite team this fall
This week in Santa Cruz County business: Santa Cruz-based crowdfunding site, Sea Dubs mark milestones; next steps for Pajaro Valley apple growers
In her weekly look at local business, Jessica M. Pasko notes highlights for Climatize and the Santa Cruz Warriors, what South County farmers are hearing in the wake of bad news from Martinelli's and plenty more comings, goings and dates to know.
Yankees news: Injury updates and painful prospect news
Bad injury news on Grisham, Stanton, and Lombard; Caballero and the pitch clock remain a story; Yanks release Brown
Is gambling the reason we have pro sports?
To hear author David Bockino tell it, gambling has always been a key ingredient of pro sports in the U.S.—it’s as American as apple pie. Bockino is the author of the new book Over/Under: An Unexpected History of Sports Betting. So what gave rise to this new wave of sports gambling? And what are we risking placing so many bets on games? Fact checking by Sierra Juarez. Your Next Listen — Prediction markets are threatening national security. Who’s gonna fix it? Connect with The Indicator — Sign up for The Indicator’s brand new newsletter — Buy the Planet Money book — Find our socials, YouTube and more! — For sponsor-free episodes, subscribe to NPR+
Why Trump’s secret and vague MOU is stirring a political storm
The text of President Donald Trump’s memorandum of understanding with Iran — when it is finally published — may not dispel his critics’ fears of a bad deal.
Corey Feldman diagnosed with 'really bad case of food poisoning,' released from hospital after mid-flight medical emergency
'Stand by Me' actor Corey Feldman has been released from the hospital following a mid-flight medical emergency on a flight to Los Angeles.
Cardinals expected to attend Brendan Sorsby's pro day
The Arizona Cardinals have already done plenty of homework on quarterback Brendan Sorsby, according to Arizona Sports' John Gambadoro.
Royal Oak shop owners say road construction is driving away business
Steelers Could Bench Aaron Rodgers, Per One Pittsburgh Reporter
Is there actually a possibility that the Pittsburgh Steelers could either bench or move on from Aaron Rodgers if he had a bad season?
Iran agreement: Bad, BATNA or both?
As the debate over a possible Iran agreement shifts from whether there will be a deal to what is in it, commentary is already racing ahead of the facts. We have not yet seen the text. We do not know the precise commitments, timelines or enforcement mechanisms — if any.
Is Bread Actually Healthy? Here's What Nutrition Experts Say
The nutrition profile of bread depends on which type it is, how you consume it, and what else you’re eating.
City & Guilds bosses awarded themselves millions in bonuses, investigation finds
Report finds Kirstie Donnelly and Abid Ismail paid bonuses ‘without authorisation or knowledge’ of superiors